Pages that link to "Q28275643"

The following pages link to Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram (Q28275643):

Displaying 46 items.

• Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors (Q26786476) (← links)
• A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care (Q26851160) (← links)
• Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells (Q28484299) (← links)
• Training-induced mitochondrial adaptation: role of peroxisome proliferator-activated receptor γ coactivator-1α, nuclear factor-κB and β-blockade (Q28578449) (← links)
• The oxazolidinone derivative locostatin induces cytokine appeasement. (Q30887007) (← links)
• Image-based screening for the identification of novel proteasome inhibitors (Q33268487) (← links)
• Therapeutic strategies for inhibiting invasion in glioblastoma (Q33426563) (← links)
• Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. (Q33766192) (← links)
• An Image-Based, High-Throughput Screening Assay for Molecules that Induce Excess DNA Replication in Human Cancer Cells (Q33800817) (← links)
• The proteasome-ubiquitin system is required for efficient killing of intracellular Streptococcus pneumoniae by brain endothelial cells (Q34165387) (← links)
• Misfolded proteins: from little villains to little helpers in the fight against cancer (Q34466592) (← links)
• Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease (Q35094132) (← links)
• Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram (Q35542866) (← links)
• Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines (Q35595695) (← links)
• Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodeficient mice (Q35609909) (← links)
• Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway (Q36562209) (← links)
• Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells (Q36837031) (← links)
• Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer (Q37315686) (← links)
• Proteasome regulators: activators and inhibitors. (Q37411350) (← links)
• The roles of endogenous retinoid signaling in organ and appendage regeneration. (Q38088191) (← links)
• The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma (Q38178169) (← links)
• Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β. (Q38817309) (← links)
• Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies. (Q39398672) (← links)
• Redox regulation of proteasome function (Q39439087) (← links)
• Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line (Q39586108) (← links)
• Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth (Q39660971) (← links)
• NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells (Q41477550) (← links)
• Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition (Q41575123) (← links)
• Proteomic screening of molecular targets of crocin (Q41951770) (← links)
• Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. (Q42176458) (← links)
• A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. (Q42675375) (← links)
• Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system (Q45229028) (← links)
• Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. (Q46185130) (← links)
• Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways. (Q47096948) (← links)
• Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. (Q53565626) (← links)
• Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition (Q57163862) (← links)
• Copper(II) Bis(diethyldithiocarbamate) Induces the Expression of Syndecan-4, a Transmembrane Heparan Sulfate Proteoglycan, via p38 MAPK Activation in Vascular Endothelial Cells (Q57791822) (← links)
• Evaluating biological activity of compounds by transcription factor activity profiling (Q58695868) (← links)
• Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death (Q58744474) (← links)
• Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening (Q60327013) (← links)
• Turning liabilities into opportunities: Off-target based drug repurposing in cancer (Q89651597) (← links)
• Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells (Q90505395) (← links)
• Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies (Q91045679) (← links)
• Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells (Q92825104) (← links)
• Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease (Q94564542) (← links)
• Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents (Q97646047) (← links)